Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 11, Number 24, 2005

Book review

Favourites:
ADD

Review article

Prospects for the Resistance to HIV Protease Inhibitors: Current Drug Design Approaches and Perspectives
pp. 3077-3090(14)
Authors: Burlet, S.; Pietrancosta, N.; Laras, Y.; Garino, C.; Quelever, G.; Kraus, J.- L.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Dihidro-β-Agarofuran Sesquiterpenes: A New Class of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in the Protozoan Parasite Leishmania
pp. 3125-3139(15)
Authors: Cortes-Selva, F.; Jimenez, I. A.; Munoz-Martinez, F.; Campillo, M.; Bazzocchi, I. L.; Pardo, L.; Ravelo, A. G.; Castanys, S.; Gamarro, F.

Favourites:
ADD

Role of Free Radicals in Sepsis: Antioxidant Therapy
pp. 3141-3158(18)
Authors: Victor, V. M.; Rocha, M.; Esplugues, J. V.; Fuente, M. D. l.

Favourites:
ADD
Favourites:
ADD

Remediation of Cellular Hypoxic Damage by Pharmacological Agents
pp. 3185-3199(15)
Authors: Minko, T.; Wang, Y.; Pozharov, V.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content